151 related articles for article (PubMed ID: 7530303)
1. Glucocorticoid-dextran conjugates as potential prodrugs for colon-specific delivery: hydrolysis in rat gastrointestinal tract contents.
McLeod AD; Friend DR; Tozer TN
J Pharm Sci; 1994 Sep; 83(9):1284-8. PubMed ID: 7530303
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid-dextran conjugates as potential prodrugs for colon-specific delivery: steady-state pharmacokinetics in the rat.
McLeod AD; Tolentino L; Tozer TN
Biopharm Drug Dispos; 1994 Mar; 15(2):151-61. PubMed ID: 7516722
[TBL] [Abstract][Full Text] [Related]
3. A glucocorticoid prodrug facilitates normal mucosal function in rat colitis without adrenal suppression.
McLeod AD; Fedorak RN; Friend DR; Tozer TN; Cui N
Gastroenterology; 1994 Feb; 106(2):405-13. PubMed ID: 7507873
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of dextran-budesonide conjugates as colon specific prodrugs for treatment of ulcerative colitis.
Varshosaz J; Emami J; Tavakoli N; Fassihi A; Minaiyan M; Ahmadi F; Dorkoosh F
Int J Pharm; 2009 Jan; 365(1-2):69-76. PubMed ID: 18804521
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of an enzyme-dependent prodrug and evaluation of its potential for colon targeting.
Pang YN; Zhang Y; Zhang ZR
World J Gastroenterol; 2002 Oct; 8(5):913-7. PubMed ID: 12378641
[TBL] [Abstract][Full Text] [Related]
6. Delivery of glucocorticoid conjugate in rat gastrointestinal tract and its treatment for ulcerative colitis.
Zhou SY; Mei QB; Liu L; Guo X; Qiu BS; Zhao DH; Cho CH
Acta Pharmacol Sin; 2001 Aug; 22(8):761-4. PubMed ID: 11749853
[TBL] [Abstract][Full Text] [Related]
7. [Characteristics of drug-release in vitro of different dextran-dexamethasone conjugates].
Zhou SY; Mei QB; Liu L; Zhang BL; Li C; Zhou J
Yao Xue Xue Bao; 2003 May; 38(5):388-91. PubMed ID: 12958847
[TBL] [Abstract][Full Text] [Related]
8. Colon-specific delivery of dexamethasone from a glucoside prodrug in the guinea pig.
Tozer TN; Rigod J; McLeod AD; Gungon R; Hoag MK; Friend DR
Pharm Res; 1991 Apr; 8(4):445-54. PubMed ID: 1871038
[TBL] [Abstract][Full Text] [Related]
9. In vitro evaluation of dexamethasone-beta-D-glucuronide for colon-specific drug delivery.
Haeberlin B; Rubas W; Nolen HW; Friend DR
Pharm Res; 1993 Nov; 10(11):1553-62. PubMed ID: 8290467
[TBL] [Abstract][Full Text] [Related]
10. Conjugation of metronidazole with dextran: a potential pharmaceutical strategy to control colonic distribution of the anti-amebic drug susceptible to metabolism by colonic microbes.
Kim W; Yang Y; Kim D; Jeong S; Yoo JW; Yoon JH; Jung Y
Drug Des Devel Ther; 2017; 11():419-429. PubMed ID: 28243064
[TBL] [Abstract][Full Text] [Related]
11. [Pharmacokinetics of site-specific delivery of dexamethasone-dextran prodrug in rat gastrointestinal tract].
Zhou SY; Mei QB; Zhou J; Liu L; Li C; Zhao DH
Yao Xue Xue Bao; 2001 May; 36(5):325-8. PubMed ID: 12584851
[TBL] [Abstract][Full Text] [Related]
12. 6A-O-[(4-biphenylyl)acetyl]-alpha-, -beta-, and -gamma-cyclodextrins and 6A-deoxy-6A-[[(4-biphenylyl)acetyl]amino]-alpha-, -beta-, and -gamma-cyclodextrins: potential prodrugs for colon-specific delivery.
Uekama K; Minami K; Hirayama F
J Med Chem; 1997 Aug; 40(17):2755-61. PubMed ID: 9276021
[TBL] [Abstract][Full Text] [Related]
13. Preparation of budesonide-dextran conjugates using glutarate spacer as a colon-targeted drug delivery system: in vitro/in vivo evaluation in induced ulcerative colitis.
Varshosaz J; Emami J; Ahmadi F; Tavakoli N; Minaiyan M; Fassihi A; Mahzouni P; Dorkoosh F
J Drug Target; 2011 Feb; 19(2):140-53. PubMed ID: 20429772
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and in vitro characterization of novel dextran-methylprednisolone conjugates with peptide linkers: effects of linker length on hydrolytic and enzymatic release of methylprednisolone and its peptidyl intermediates.
Penugonda S; Kumar A; Agarwal HK; Parang K; Mehvar R
J Pharm Sci; 2008 Jul; 97(7):2649-64. PubMed ID: 17853426
[TBL] [Abstract][Full Text] [Related]
15. Macromolecular prodrugs. XVI. Colon-targeted delivery--comparison of the rate of release of naproxen from dextran ester prodrugs in homogenates of various segments of the pig gastrointestinal (GI) tract.
Larsen C; Harboe E; Johansen M; Olesen HP
Pharm Res; 1989 Dec; 6(12):995-9. PubMed ID: 2622863
[TBL] [Abstract][Full Text] [Related]
16. Structural effects of N-aromatic acyl-amino acid conjugates on their deconjugation in the cecal contents of rats: implication in design of a colon-specific prodrug with controlled conversion rate at the target site.
Kong H; Kim H; Do H; Lee Y; Hong S; Yoon JH; Jung Y; Kim YM
Biopharm Drug Dispos; 2011 Sep; 32(6):343-54. PubMed ID: 21800327
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and properties of dextran-nalidixic acid ester as a colon-specific prodrug of nalidixic acid.
Lee JS; Jung YJ; Doh MJ; Kim YM
Drug Dev Ind Pharm; 2001 Apr; 27(4):331-6. PubMed ID: 11411900
[TBL] [Abstract][Full Text] [Related]
18. Sulfate-conjugated methylprednisolone: evaluation as a colon-specific methylprednisolone prodrug and comparison with sulfate-conjugated prednisolone and dexamethasone.
Kong H; Kim Y; Lee Y; Choi B; Jung S; Jung Y; Kim YM
J Drug Target; 2009 Feb; 17(2):159-67. PubMed ID: 18988065
[TBL] [Abstract][Full Text] [Related]
19. Budesonide-beta-D-glucuronide: a potential prodrug for treatment of ulcerative colitis.
Nolen H; Fedorak RN; Friend DR
J Pharm Sci; 1995 Jun; 84(6):677-81. PubMed ID: 7562403
[TBL] [Abstract][Full Text] [Related]
20. Celecoxib coupled to dextran via a glutamic acid linker yields a polymeric prodrug suitable for colonic delivery.
Lee Y; Kim J; Kim W; Nam J; Jeong S; Lee S; Yoo JW; Kim MS; Jung Y
Drug Des Devel Ther; 2015; 9():4105-13. PubMed ID: 26251576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
